pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·3h ago·1 min read
save

Federal Appeals Judges Reject HHS Arguments in Humana Medicare Advantage Audit Lawsuit

Oct 5, 2026·read at STAT ↗RegulatoryNeutral

Federal appeals judges on Monday rebuked the Health and Human Services Department's arguments in a hearing on Humana's lawsuit challenging a new Medicare Advantage audit rule.

Humana, the nation's second-largest Medicare Advantage insurer, sued in 2023 claiming the final risk adjustment data validation (RADV) rule differed substantially from the proposed version and that the agency failed to give stakeholders adequate notice or opportunity to comment, which it said would increase audit costs.

A district court had already struck down the rule in September 2025, and HHS appealed that decision in November. During the oral arguments, the three-judge panel of the Fifth Circuit questioned the administration's justification for the rule change and highlighted concerns that the rule could harm insurers.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Judges skewer HHS arguments in hearing over Medicare Advantage audits lawsuit”

read at STAT ↗
523 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Protara Therapeutics, Inc.7LILLY
drugs
pirtobrutinib
topics
Small Molecule2CLL

related stories

  • 3h agoSTAT+: Nobel-winning optogenetics research has led to experimental treatments for blindness and Alzheimer’sSTAT
  • 5h agoSTAT+: New Trump regulations would clean up health care pricing disclosuresSTAT
  • 7h agoSTAT+: Prices, prices, pricesSTAT
  • 8h agoSTAT+: Utah plows ahead with more health AI pilots for prescriptions, women’s healthSTAT
  • 10h agoOptogenetics researchers win a Nobel Prize; Roche bets on Alector brain drugBioPharma Dive